COVID-19 and diabetes: Knowledge in progress
暂无分享,去创建一个
Akhtar Hussain | A. Hussain | B. Bhowmik | Bishwajit Bhowmik | Nayla Cristina do Vale Moreira | A. Hussain
[1] Rajaa Al-Raddadi,et al. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome , 2017, American journal of respiratory and critical care medicine.
[2] D. Gurwitz. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics , 2020, Drug development research.
[3] Jianwen Gu,et al. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed , 2020, Diabetes Research and Clinical Practice.
[4] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[5] Heshui Shi,et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.
[6] Jin-Kui Yang,et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.
[7] Grant Pj,et al. Type 2 diabetes: an atherothrombotic syndrome. , 2005 .
[8] Shaoqiang Li,et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.
[9] J. Chan,et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[10] A. Esteghamati,et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2020, Diabetes Research and Clinical Practice.
[11] D. Wang,et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.
[12] Sen Li,et al. Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study , 2019, Diabetes & metabolism journal.
[13] Mario Plebani,et al. Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.
[14] Chuan Qin,et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.
[15] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[16] Sumithra Kumar,et al. Efficacy and safety of hydroxychloroquine when added to stable insulin therapy in combination with metformin and glimepiride in patients with type 2 diabetes compare to sitagliptin , 2018, International Journal of Basic & Clinical Pharmacology.
[17] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[18] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[19] G. Nunnari,et al. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? , 2020, European Review for Medical and Pharmacological Sciences.
[20] J. Baillie,et al. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.
[21] Jing Liu,et al. Updated Approaches against SARS-CoV-2 , 2020, Antimicrobial Agents and Chemotherapy.
[22] I. Macdonald,et al. Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans , 2018, The Journal of clinical endocrinology and metabolism.
[23] Rui Ji,et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[24] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[25] Jianjun Gao,et al. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. , 2020, Bioscience trends.
[26] M. He,et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. , 2020, Zhonghua xin xue guan bing za zhi.
[27] Xiaoxin Yin,et al. Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats , 2015, Cardiology.
[28] A. Anzueto,et al. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia , 2008, European Respiratory Journal.
[29] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[30] Malik Peiris,et al. Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.
[31] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[32] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[33] J. Kastrup,et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. , 1989, The European respiratory journal.
[34] S. Geerlings,et al. Immune dysfunction in patients with diabetes mellitus (DM). , 1999, FEMS immunology and medical microbiology.
[35] S. Frøland,et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.
[36] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[37] Dylan H. Morris,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.
[38] Mikiko Senga,et al. Middle East Respiratory Syndrome. , 2017, The New England journal of medicine.
[39] F. Jamali,et al. Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. , 1998, Life sciences.
[40] A J Scheen,et al. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. , 1992, Diabete & metabolisme.
[41] World Health Organization,et al. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance , 2020, Pediatria i Medycyna Rodzinna.
[42] Jun Zhou,et al. Letter to the Editor: Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China , 2020, Metabolism.
[43] H. Randeva,et al. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. , 2011, Immunobiology.
[44] M. Simionescu,et al. Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters. , 1997, The European respiratory journal.
[45] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[46] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[47] Giovanni Sparacino,et al. Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy). , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[48] R. Booy,et al. Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia , 2016, Virologica Sinica.
[49] N. Horvat,et al. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity , 2019, BMC Infectious Diseases.
[50] James Chamberlain,et al. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes , 2016, Annals of Internal Medicine.
[51] R. Haynes,et al. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial. , 2002, Diabetes research and clinical practice.
[52] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[53] Katri Jalava,et al. First respiratory transmitted food borne outbreak? , 2020, International Journal of Hygiene and Environmental Health.
[54] Jun Zhou,et al. Diabetes patients with COVID-19 need better care. , 2020, Metabolism: clinical and experimental.
[55] John R. Petrie,et al. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms , 2017, The Canadian journal of cardiology.
[56] Paul Garner,et al. SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.
[57] Yichong Li,et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.
[58] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[59] Antonio Pérez,et al. Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖) , 2014, Journal of diabetes.
[60] A. Adamson,et al. Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection. , 2013, Virology.
[61] Xiang Xie,et al. COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.
[62] Bo Li,et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.
[63] F. Zhang,et al. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis. , 2013, Annals of hepatology.
[64] S. Rozelle,et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review , 2020, Infectious Diseases of Poverty.
[65] A. Sinclair,et al. New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[66] J. Clore,et al. Glucocorticoid-induced hyperglycemia. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[67] Giuliano Rizzardini,et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[68] D. Solomon,et al. Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases. , 2010, Arthritis and rheumatism.
[69] A. Avogaro,et al. Prevalence and impact of diabetes among people infected with SARS-CoV-2 , 2020, Journal of Endocrinological Investigation.
[70] F. Strollo,et al. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used) , 2020, Diabetes Research and Clinical Practice.
[71] A. Arroliga,et al. Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia , 2018, Proceedings.
[72] S. Knapp,et al. Diabetes and Infection: Is There a Link? - A Mini-Review , 2012, Gerontology.
[73] Derek G Cook,et al. Diabetes and infection: assessing the association with glycaemic control in population-based studies. , 2016, The lancet. Diabetes & endocrinology.
[74] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.